Paid Clinical Trials New Haven

Discover 703 paid clinical trials in New Haven, Connecticut. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 703

Observational StudyPancreatic Cancer Early Detection Consortium

Recruiting

Sponsor:

Arbor Research Collaborative for Health

Location:

New Haven CT, White Plains NY, Hackensack NJ, New York NYshow 39 more

Code:

NCT04970056

Conditions

Pancreas Cancer

Pancreas Cyst

Pancreatic Ductal Adenocarcinoma

Genetic Predisposition

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Accepted

FT825/ONO-8250 & Monoclonal AntibodiesFT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, with or Without Monoclonal Antibodies in Advanced Solid Tumors

Recruiting

PHASE1

Sponsor:

Fate Therapeutics

Location:

New Haven CT, New York NY, Philadelphia PA, Detroit MIshow 10 more

Code:

NCT06241456

Conditions

Advanced Solid Tumor

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

FT825

Fludarabine

Cyclophosphamide

Bendamustine

Docetaxel

NutritionStrength and Muscle Related Outcomes for Nutrition and Lung Function in CF

Recruiting

Sponsor:

Jaeb Center for Health Research

Location:

New Haven CT, Hawthorne NY, New Hyde Park NY, Boston MAshow 18 more

Code:

NCT05639556

Conditions

Cystic Fibrosis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

BMI and lean mass index from DXA

Anthropometric Measurements

Hand-grip strength

Six-minute walk Test

Sit-to-Stand Test

Alisertib & Endocrine TherapyA Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer

Recruiting

PHASE2

Sponsor:

Puma Biotechnology, Inc.

Location:

New Haven CT, Horsham PA, Richmond VA, Chapel Hill NCshow 18 more

Code:

NCT06369285

Conditions

Hormone Receptor Positive HER-2 Negative Breast Cancer

Metastatic Breast Cancer

Recurrent Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Alisertib

Endocrine therapy

BI 1703880 & EzabenlimabA Study to Test How Different Doses of BI 1703880 in Combination With Ezabenlimab Are Tolerated in People With Different Types of Advanced Cancer (Solid Tumours)

Recruiting

PHASE1

Sponsor:

Boehringer Ingelheim

Location:

New Haven CT, Hackensack NJ, Los Angeles CA

Code:

NCT05471856

Conditions

Solid Tumors

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

BI 1703880

Ezabenlimab

Nutrition InterventionFood for Thought - a Nutrition Intervention for Women Undergoing Active Treatment for Triple Negative Breast Cancer

Recruiting

Sponsor:

Ohio State University Comprehensive Cancer Center

Location:

New Haven CT, Columbus OH

Code:

NCT06582615

Conditions

Anatomic Stage II Breast Cancer AJCC V8

Anatomic Stage III Breast Cancer AJCC V8

Triple-Negative Breast Carcinoma

Eligibility Criteria

Sex: Female

Age: 40 - 65

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Cognitive Assessment

Dietary Intervention

Medical Device Usage and Evaluation

Questionnaire Administration

VITRAKVIStudy to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusion Cancer Which is Locally Advanced or Spread From the Place Where it Started to Other Places in the Body

Recruiting

Sponsor:

Bayer

Location:

Multiple Locations, New Haven CT, New York NY, Staten Island NYshow 42 more

Code:

NCT04142437

Conditions

Locally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene Fusion

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

larotrectinib(Vitrakvi, BAY2757556)

AnifrolumabA 2-stage, Phase III Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus Erythematosus

Recruiting

PHASE3

Sponsor:

AstraZeneca

Location:

New Haven CT, Midland Park NJ, New York NY, Brooklyn NYshow 43 more

Code:

NCT06015737

Conditions

Cutaneous Lupus Erythematosus

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Not accepted

Interventions

Anifrolumab

Placebo

Vepdegestrant & PF-07220060A Study to Learn About Vepdegestrant When Given With PF-07220060 to People With Advanced or Metastatic Breast Cancer.

Recruiting

PHASE1

PHASE2

Sponsor:

Pfizer

Location:

New Haven CT, Trumbull CT, Commack NY, Harrison NYshow 18 more

Code:

NCT06206837

Conditions

Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

vepdegestrant

PF-07220060

Digital WellnessAssessing the Effectiveness of Digital Wellness Modules on Perceived Quality of Life

Recruiting

Sponsor:

Yale University

Location:

New Haven CT

Code:

NCT05810259

Conditions

Wellness

Quality of Life

Anxiety

Depression

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Accepted

Interventions

Caravan Wellness app